AFLD 2012 FFR vs Respondent M97

Facts
The French Rugby Federation (Fédération Française de Rugby, FFR) charges respondent M97 for a violation of the Anti-Doping Rules. During a match on January 18, 2012, a sample was taken for a doping test. The sample tested positive on terbutaline which is a prohibited substance according the World Anti-Doping Agency (WADA) prohibited list. Terbutaline is regarded as a specified substance.

History
The respondent explains that the positive test is caused by medications he used to treat asthma. He has proof of negligence by the French Anti-Doping Agency for not receiving a Therapeutic Use Exemption (Tue).

Decision
1. The respondent receives a warning.
2. The decision of March 8, 2012, from the disciplinary committee of the FFR is cancelled.
3. The decision will start on the date of notification.
4. The decision will be published and sent to the parties involved.

Original document

Parameters

Legal Source
National Decisions
Date
8 November 2012
Original Source
French Anti-Doping Agency (AFLD)
Country
France
Language
French
ADRV
Adverse Analytical Finding / presence
Legal Terms
Reprimand / warning
Sport/IFs
Rugby (WR) - World Rugby
Other organisations
Agence Française de Lutte contre le Dopage (AFLD) - French Anti-Doping Agency
Fédération Française de Rugby (FFR) - French Rugby Federation
Laboratories
Paris, France: Agence Française de Lutte contre le Dopage (AFLD)
Doping classes
S3. Beta-2 Agonists
Substances
Terbutaline
Medical terms
Asthma
Therapeutic Use Exemption (TUE)
Document type
Pdf file
Date generated
3 March 2014
Date of last modification
12 March 2014
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin